The commercial distribution of medical devices in New Zealand is supervised by the Medicines and Medical Devices Safety Authority which is commonly referred to as Medsafe. This agency operates under the Ministry of Health and is responsible for enforcing the Medicines Act 1981 as well as the Medicines Regulations 1984. Their primary duties involve managing the national registry and establishing quality benchmarks while monitoring the safety of therapeutic products across the market.
New Zealand categorizes medical devices and In Vitro Diagnostics (IVD) based on their potential risk to patients in alignment with international regulatory models. This tiered system determines the level of scrutiny required during the registration phase.
To successfully introduce a product to the New Zealand healthcare sector, manufacturers must satisfy several technical and quality criteria. These requirements include the verification of compliance with international standards specifically ISO 13485. Manufacturers are also expected to prepare a comprehensive technical file detailing product specifications and testing protocols along with manufacturing workflows and risk mitigation strategies. It is important to note that all official submissions and supporting technical data must be presented in English.
The administrative process for market entry relies on a structured sequence of evaluations involving a local presence.
Foreign manufacturers are required to designate a New Zealand representative. This entity is responsible for maintaining the technical documentation summary which encompasses product identifiers and manufacturing data. The representative also ensures that the device adheres to applicable safety standards and verifies the validity of the formal declaration of conformity (DoC).
The process begins with a completeness check by Medsafe followed by in-depth evaluations of the technical and clinical data to confirm safety and performance. Medsafe also reviews the manufacturer's authorization and technical support capabilities to ensure that equipment supply and service needs can be met. Upon successful verification, a registration certificate is issued. This registration must be maintained through annual data updates and the regular submission of review reports.
We act as your officially designated New Zealand representative to fulfill the legal requirement for a local entity to manage your WAND notification and technical communications with Medsafe.
Our experts conduct a detailed review of your product's intended use and technical features to determine its correct risk class in alignment with current MDR frameworks and New Zealand regulations.
We assist in the preparation of the essential technical summary required by Medsafe including the general safety and performance requirements (GSPR) as well as risk management reports and the finalization of the DoC.
We manage the entire submission process within the WAND database to ensure that all product data and manufacturer information along with technical evidence are accurately reported for a smooth listing.
Our team provides guidance on presenting clinical evidence and technical testing data to satisfy Medsafe's evaluations regarding the safety and effectiveness of high-risk medical devices.
We ensure your market access remains uninterrupted by managing the mandatory annual updates for your registration and coordinating the submission of required review reports to the authorities.
We assist in establishing local monitoring procedures to identify and report any safety incidents or malfunctions to Medsafe to ensure your ongoing adherence to post-market surveillance requirements.
If you are interested in our New Zealand Medsafe registration services and wish to secure your market position, please feel free to contact us.
We're open for any suggestion or just have a chat with us.
Tel: Email: WhatsAPP